Tyra Biosciences Inc.

TYRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$25.65

-$0.08 (-0.31%)

At close: Sep 21, 2026, 4:00 PM ET

$26.04

+$0.39 (+1.52%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.54B

Enterprise Value $1.18B

Beta 0.73

Average Volume 767.25K

Shares Outstanding (Diluted) 65.99M

Shares Change YoY 10.81%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US90240B1061

Price Performance

Price Change 1M -1.3%

Price Change 3M -14.7%

Price Change 6M -30.1%

Price Change YTD -4.3%

Price Change 1Y 99.0%

Price Change 3Y 80.1%

Price Change 5Y 45.7%

1M CAGR (ann.) -4.6%

1Y CAGR (ann.) 111.8%

5Y CAGR (ann.) N/A

All-Time CAGR -0.2%

Valuation

PE Ratio -10.69

Forward PE N/A

PEG Ratio 0.39

Forward PEG -1.27

PS Ratio N/A

Forward PS 452.50

PB Ratio 4.33

P/FCF Ratio -13.92

P/Adj. FCF Ratio -10.69

P/OCF Ratio -15.45

EV/Sales N/A

EV/EBIT -7.96

EV/EBITDA -7.99

EV/FCF -10.76

Earnings Yield -9.4%

FCF Yield -7.2%

Adj. FCF Yield -9.4%

Financial Health

Net Cash $353.94M

Total Debt $5.58M

Cash & Short-Term Investments $353.94M

Total Assets $383.36M

Current Ratio 14.91

Quick Ratio 14.91

Debt / Equity Ratio 0.02

Debt / EBITDA -0.04

Debt / FCF -0.05

OCF / Debt -19.64

Interest Coverage 0.00

Altman Z-Score 29.14

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -30.3%

Returns

Return on Assets -38.8%

Return on Equity -46.4%

Return on Invested Capital -44.8%

Return on Capital Employed -44.7%

Return on Tangible Assets -38.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -18.1%

EPS CAGR 5Y -17.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y -26.2%

FCF CAGR 5Y -25.9%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 7

EPS Growth Next 3Y -9.7%

Revenue Growth Next 3Y N/A

Earnings Date Nov 3, 2026

EPS Estimate (next Q) -$0.66

EPS Growth Est (next Q) 32.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $50.67

Price Target Upside 97.5%

Cash Flow

Operating Cash Flow $-109.65M

Free Cash Flow $-109.9M

Adj. Free Cash Flow $-143.18M

FCF Per Share -$1.67

OCF Per Share -$1.66

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-138K

Operating Income $-160.46M

EBITDA $-148.03M

Net Income $-148.57M

EPS (Diluted) -$2.40

Revenue / Employee N/A

Profit / Employee $-1.71M

Employees 87